Information  X 
Enter a valid email address

Independent Oil &Gas (IOG)

  Print      Mail a friend

Wednesday 25 July, 2018

Independent Oil &Gas

Appointment of Peel Hunt as Joint-Broker

RNS Number : 6538V
Independent Oil & Gas PLC
25 July 2018
 

25 July 2018

Independent Oil and Gas plc

 

Appointment of Peel Hunt as Joint-Broker

 

Independent Oil and Gas plc ("IOG" or the "Company"), the development and production focused Oil and Gas Company, is pleased to announce that it has appointed Peel Hunt LLP as joint-broker to the Company alongside the existing broker and Nominated Advisor, finnCap Limited with immediate effect.

Andrew Hockey, CEO of IOG commented:

"We are extremely pleased to be working with Peel Hunt as we progress the funding of our dual gas hub development project.  We look forward to working closely with them in conjunction with our existing brokers finnCap."

 

-ENDS-

 

Enquiries:

Independent Oil and Gas plc

Andrew Hockey (CEO)

James Chance (CFO)

+44 (0) 20 3879 0510

finnCap Ltd

Christopher Raggett / Anthony Adams

(Corporate Finance)

Camille Gochez (Corporate Broking)

+44 (0) 20 7220 0500

Peel Hunt LLP

Richard Crichton

David McKeown

+44 (0) 20 7418 8900

Camarco

Georgia Edmonds / Tom Huddart / Monique Perks

+44 (0) 20 3757 4980

About Independent Oil and Gas:

IOG owns substantial low risk, high value gas Reserves in the UK Southern North Sea.  The Company is targeting a 2P peak production rate in excess of 200 MMcfd (c. 35,000 Boe/d) from its substantial current portfolio (2P Reserves of 303 bcf) via an efficient hub strategy.  Alongside this it continues to pursue value accretive acquisitions, to generate significant shareholder returns.  All IOG's licences are owned 100% and operated by IOG.

 

Further information can be found on www.independentoilandgas.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
APPRIMBTMBATTAP

a d v e r t i s e m e n t